Skip to content

Clinical trials

Phase 2 Immunoglobulin Light-chain Amyloidosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Phase: Phase 2 Country / region: United States Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20042
20051
20061
20074
20083
20091
20101
20121
20132
20141
20162
20173
20183
20201
20212
20221
20232
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated5
Active, not recruiting4
Recruiting3
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Medical Center7
Mayo Clinic4
Memorial Sloan Kettering Cancer Center4
Barbara Ann Karmanos Cancer Institute3
Prothena Biosciences Ltd.3
SWOG Cancer Research Network3
Case Comprehensive Cancer Center2
Herbert Irving Comprehensive Cancer Center2
Medical College of Wisconsin2
Alexion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis48
Multiple Myeloma26
Neoplasms, Plasma Cell16
Leukemia, Lymphocytic, Chronic, B-Cell8
Amyloidosis7
Burkitt Lymphoma7
Lymphoma7
Lymphoma, B-Cell, Marginal Zone7
Lymphoma, Follicular7
Lymphoma, Large B-Cell, Diffuse7

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.